Treat the decline claim as a plausible hypothesis that has been asserted far more often than it has been measured
Ideal candidates include patients with acute sports injuries seeking accelerated recovery, chronic tendinopathies that have not responded to conservative management, post-surgical orthopedic cases where optimized healing is a priority, inflammatory joint conditions where traditional treatments have fallen short, and autoimmune-mediated pain where immune modulation may provide benefit
Using endogenous antioxidant above may have already given away the answer
Research parameters include angiogenic signaling, growth-factor expression, nitric oxide pathway activity, peptide stability, and formulation-dependent transport characteristics
Most researchers report sustained benefits lasting 4 to 6 months post-cycle, which is why cycles are typically repeated only two to three times annually